Developer docs
API playgroundTry for free, no card

Search company profiles

Signum Technologies

Full company profile

uuid000brqq

Namestring
Signum Technologies
Legal namestring
Signum Technologies, Inc.
Websiteurl
signum-tech.com
Company typeenum
Private
Founded yearint
2022
Descriptiontext

Signum Technologies is a privately held Delaware-incorporated computer vision and AI company founded in 2022 and headquartered in Radnor, Pennsylvania. The company develops ROSIE, a patented passive optical physiology monitoring software that uses video and image analysis to detect vital sign anomalies in individuals without physical contact, enabling population-scale contactless health screening and continuous clinical monitoring. The company's core technology is positioned across two primary verticals: health security, where it targets U.S. federal agencies such as TSA, DHS, and CBP for screening at airports, maritime ports, and border crossings; and healthcare, where it sells to hospitals, burn centers, NICUs, senior living facilities, and telehealth providers for contactless vital sign monitoring and remote diagnostics.

Signum was incubated through FedTech, a U.S. government-funded technology incubator that selected the founding team to commercialize biosensor technology originally developed in response to Covid-19-era healthcare and security needs. The company maintains strategic innovation-partner relationships with MITRE, U.S. National Laboratories, and federal agencies, and lists a separate PenFed Foundation grant in its funding history. Its leadership team is led by Sean Freitag (CEO, former Blackstone Principal and 14-year U.S. Navy SEAL), Andrew Gehman (COO, founder of Black Eagle Defense), and Mark Farmer (CTO, 24-year software engineering veteran).

The business model is enterprise sales-led with no publicly disclosed pricing, no published ARR or customer logos, and a stated headcount of 1–10 employees. The company is pre-commercial in terms of disclosed revenue and is currently raising capital; as of March 2026, an SEC Form D exempt securities offering had raised approximately $1.2 million toward a $1.725 million target, with $200,000 of gross proceeds allocated to executive and director compensation. Geographic footprint is domestic (USA) and the company has no disclosed international operations.

Short descriptiontext

Signum Technologies is a U.S. computer vision and AI company building ROSIE, a patented contactless vital sign monitoring platform, and selling it to federal agencies for health-security screening at airports, ports, and borders, and to healthcare providers for remote patient monitoring.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersRadnor, United States
HQ citystring
Radnor
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
contactless vital sign monitoring, passive optical physiology software, computer vision health screening, telehealth remote monitoring, health security screening
Industry2 codes
PRIMARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLACAFAE
Elderly/Frail & Assisted Living Connected Care (PERS/Fall Detection)
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Industrial Instruments For Measurement, Display, And Control3823
Product category
Computer Vision Healthcare Monitoring Software
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1SEC Exempt Securities Offering
TypeHardware Sales
Description

The company is raising capital through SEC Form D exempt securities offering targeting $1,725,000 with $1,199,999 already sold. $200,000 of gross proceeds allocated to executive and director payments.

sec.gov
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Others
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1ROSIE
Description

Patented passive optical physiology monitoring software that enables scanning of large numbers of individuals and quickly identifies individuals whose vital signs are outside normal parameters without patient contact. Used for vital sign monitoring in healthcare and health security applications.

signum-tech.com
Core offering1 text field

Signum Technologies develops and sells ROSIE, a patented passive optical physiology monitoring software that uses computer vision and artificial intelligence to perform contactless vital sign monitoring. The product scans individuals in bulk to identify those whose vital signs fall outside normal parameters without any physical contact, enabling deployment in healthcare (senior living, NICUs, burn centers, telehealth) and government health security (airports, ports, border crossings) settings.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Enables scanning of large numbers of individuals to quickly identify vital sign anomalies
+3 more records
Product overview1 text field

Signum Technologies offers a unified product portfolio centered on ROSIE, their patented passive optical physiology monitoring software. The core ROSIE product enables contactless vital sign monitoring through computer vision and AI, supporting two main solution categories: Healthcare Solutions (covering senior living, burn centers, NICUs, and telehealth integration) and Health Security Solutions (for airports, ports, and border crossings). All offerings leverage the same underlying ROSIE technology platform for passive optical scanning of vital signs without patient contact.

Product and service1 record
1ROSIE Vital Sign Monitoring
CategoryComputer Vision Healthcare Monitoring Software
Description

Patented passive optical physiology monitoring software that uses computer vision and AI to scan large numbers of individuals and quickly identify those whose vital signs are outside normal parameters, providing initial health assessment without any patient contact. Used by federal agencies for health screening at critical infrastructure (airports, ports, border crossings) and by healthcare providers for contactless patient monitoring.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-01-01
Description

Signum Technologies was founded in 2022 in collaboration with FedTech, a USG funded technology incubator. FedTech selected Signum to commercialize groundbreaking biosensor technology developed in response to urgent healthcare and security needs arising from the Covid-19 pandemic. FedTech serves as a deep tech innovation catalyst for the company.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

MITRE is listed as an innovation partner of Signum Technologies. The partnership contributes to the company's mission of transforming state-of-the-art technologies into tangible solutions for society's most pressing challenges.

3US National Laboratories
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Signum Technologies collaborates closely with US National Laboratories to transform state-of-the-art technologies into tangible solutions that tackle society's most pressing challenges. The company works at the forefront of innovation using advanced tools to address critical problems facing humanity.

signum-tech.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Signum Technologies collaborates with Federal Agencies as part of its mission to transform state-of-the-art technologies into solutions addressing society's most pressing challenges. The company leverages these partnerships to develop and deploy health security technologies.

Strategic tierMinorTypeOthers
Description

Sean Freitag, CEO of Signum Technologies, serves on the board of directors of the Navy SEAL Foundation, which provides immediate and ongoing support and assistance to the Naval Special Warfare community and its families. This represents a personal leadership commitment rather than a commercial partnership.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Contact-free continuous patient monitoring for hospitals and senior living, competing for the same clinical RPM and senior-living safety budgets that Signum targets.

TypeEmerging player
Description

AI-powered ambient sensing platform for healthcare facilities that combines computer vision with vital sign and behavior monitoring, overlapping Signum's healthcare and telehealth vision.

TypeDirect peer
Description

Provides contactless vital signs monitoring (heart rate, SpO2, blood pressure, stress) via video from smartphones or cameras, directly overlapping ROSIE's core passive optical physiology capability across both healthcare and workforce screening.

TypeEmerging player
Description

Continuous health monitoring via wearable and contact-free sensors for clinical RPM, an adjacent competitor for the same healthcare and senior-living decision-makers.

5Xandar Kardian
TypeEmerging player
Description

Radar-based vital sign and occupancy monitoring for healthcare and smart-building applications, an adjacent contactless monitoring peer competing for similar remote patient and facility monitoring budgets.

6Biovitals
TypeEmerging player
Description

Contactless physiological monitoring using video analysis for clinical and remote patient use cases, a closer emerging competitor in the same contactless vitals category.

TypeDirect peer
Description

Developer of TransDERMAL and Anura platforms that extract vital signs and health risk indicators from video, a direct technological analogue to ROSIE's AI/computer-vision vital sign approach.

TypeBroad incumbent
Description

Large defense-tech incumbent building AI sensing and surveillance for DHS/CBP and other federal agencies; a strategic reference point for AI-driven critical-infrastructure security customers that Signum is also targeting.

TypeDirect peer
Description

Uses cameras and computer vision for contactless vital sign and activity monitoring in clinical and senior care settings, closely mirroring Signum's healthcare and senior living use cases.

TypeEmerging player
Description

Computer vision platform for contact-free health monitoring in senior living and home care, addressing the same elderly/frail and assisted-living customer segment as Signum.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Signum Technologies

Computer Vision Healthcare Monitoring Softwaresignum-tech.com

Signum Technologies is a U.S. computer vision and AI company building ROSIE, a patented contactless vital sign monitoring platform, and selling it to federal agencies for health-security screening at airports, ports, and borders, and to healthcare providers for remote patient monitoring.

What Signum Technologies does

Signum Technologies is a privately held Delaware-incorporated computer vision and AI company founded in 2022 and headquartered in Radnor, Pennsylvania. The company develops ROSIE, a patented passive optical physiology monitoring software that uses video and image analysis to detect vital sign anomalies in individuals without physical contact, enabling population-scale contactless health screening and continuous clinical monitoring. The company's core technology is positioned across two primary verticals: health security, where it targets U.S. federal agencies such as TSA, DHS, and CBP for screening at airports, maritime ports, and border crossings; and healthcare, where it sells to hospitals, burn centers, NICUs, senior living facilities, and telehealth providers for contactless vital sign monitoring and remote diagnostics.

Signum was incubated through FedTech, a U.S. government-funded technology incubator that selected the founding team to commercialize biosensor technology originally developed in response to Covid-19-era healthcare and security needs. The company maintains strategic innovation-partner relationships with MITRE, U.S. National Laboratories, and federal agencies, and lists a separate PenFed Foundation grant in its funding history. Its leadership team is led by Sean Freitag (CEO, former Blackstone Principal and 14-year U.S. Navy SEAL), Andrew Gehman (COO, founder of Black Eagle Defense), and Mark Farmer (CTO, 24-year software engineering veteran).

The business model is enterprise sales-led with no publicly disclosed pricing, no published ARR or customer logos, and a stated headcount of 1–10 employees. The company is pre-commercial in terms of disclosed revenue and is currently raising capital; as of March 2026, an SEC Form D exempt securities offering had raised approximately $1.2 million toward a $1.725 million target, with $200,000 of gross proceeds allocated to executive and director compensation. Geographic footprint is domestic (USA) and the company has no disclosed international operations.

Signum Technologies firmographics

Firmographics
Name
Signum Technologies
Legal name
Signum Technologies, Inc.
Website
https://signum-tech.com
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
1–10 employees
Short description
Signum Technologies is a U.S. computer vision and AI company building ROSIE, a patented contactless vital sign monitoring platform, and selling it to federal agencies for health-security screening at airports, ports, and borders, and to healthcare providers for remote patient monitoring.
Ownership category
akta.pro rank

Signum Technologies industry classification

Industry
Product category
Computer Vision Healthcare Monitoring Software
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Industrial Instruments For Measurement, Display, And Control (3823)
akta.pro industry
PRIMARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLACAFAE
Elderly/Frail & Assisted Living Connected Care (PERS/Fall Detection)
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms

Keywords

  • Contactless vital sign monitoring
  • Passive optical physiology software
  • Computer vision health screening
  • Telehealth remote monitoring
  • Health security screening

Where Signum Technologies is headquartered

Location

Headquarters

HQ city
Radnor
HQ country
United States
HQ region
North America

Markets served

Signum Technologies business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Others

Revenue model

  1. SEC Exempt Securities Offering: The company is raising capital through SEC Form D exempt securities offering targeting $1,725,000 with $1,199,999 already sold. $200,000 of gross proceeds allocated to executive and director payments.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Signum Technologies product offering

Product offering

Core offering

Signum Technologies develops and sells ROSIE, a patented passive optical physiology monitoring software that uses computer vision and artificial intelligence to perform contactless vital sign monitoring. The product scans individuals in bulk to identify those whose vital signs fall outside normal parameters without any physical contact, enabling deployment in healthcare (senior living, NICUs, burn centers, telehealth) and government health security (airports, ports, border crossings) settings.

Product overview

Signum Technologies offers a unified product portfolio centered on ROSIE, their patented passive optical physiology monitoring software. The core ROSIE product enables contactless vital sign monitoring through computer vision and AI, supporting two main solution categories: Healthcare Solutions (covering senior living, burn centers, NICUs, and telehealth integration) and Health Security Solutions (for airports, ports, and border crossings). All offerings leverage the same underlying ROSIE technology platform for passive optical scanning of vital signs without patient contact.

Differentiator

Problem solved

Functional benefit

Brands

  • ROSIE: Patented passive optical physiology monitoring software that enables scanning of large numbers of individuals and quickly identifies individuals whose vital signs are outside normal parameters without patient contact. Used for vital sign monitoring in healthcare and health security applications.

Products and services

  • ROSIE Vital Sign Monitoring Patented passive optical physiology monitoring software that uses computer vision and AI to scan large numbers of individuals and quickly identify those whose vital signs are outside normal parameters, providing initial health assessment without any patient contact. Used by federal agencies for health screening at critical infrastructure (airports, ports, border crossings) and by healthcare providers for contactless patient monitoring.

Quantifiable outcome

  • Enables scanning of large numbers of individuals to quickly identify vital sign anomalies
  • +3 more outcomes

Companies that use Signum Technologies

Customer profile

Segments3 records

Ideal customer profiles2 records

Signum Technologies technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature2 records

Signum Technologies partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • FedTechcoreStrategic or Co-development Partner · 1 January 2022Signum Technologies was founded in 2022 in collaboration with FedTech, a USG funded technology incubator. FedTech selected Signum to commercialize groundbreaking biosensor technology developed in response to urgent healthcare and security needs arising from the Covid-19 pandemic. FedTech serves as a deep tech innovation catalyst for the company.
  • MITREcoreStrategic or Co-development PartnerMITRE is listed as an innovation partner of Signum Technologies. The partnership contributes to the company's mission of transforming state-of-the-art technologies into tangible solutions for society's most pressing challenges.
  • US National LaboratoriescoreStrategic or Co-development PartnerSignum Technologies collaborates closely with US National Laboratories to transform state-of-the-art technologies into tangible solutions that tackle society's most pressing challenges. The company works at the forefront of innovation using advanced tools to address critical problems facing humanity.
  • Federal AgenciescoreStrategic or Co-development PartnerSignum Technologies collaborates with Federal Agencies as part of its mission to transform state-of-the-art technologies into solutions addressing society's most pressing challenges. The company leverages these partnerships to develop and deploy health security technologies.
  • Navy SEAL FoundationminorOthersSean Freitag, CEO of Signum Technologies, serves on the board of directors of the Navy SEAL Foundation, which provides immediate and ongoing support and assistance to the Naval Special Warfare community and its families. This represents a personal leadership commitment rather than a commercial partnership.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Signum Technologies competitors and assessment

Company assessment

Emerging players

  • EarlySense: Contact-free continuous patient monitoring for hospitals and senior living, competing for the same clinical RPM and senior-living safety budgets that Signum targets.
  • Care.ai: AI-powered ambient sensing platform for healthcare facilities that combines computer vision with vital sign and behavior monitoring, overlapping Signum's healthcare and telehealth vision.
  • BioIntellisense: Continuous health monitoring via wearable and contact-free sensors for clinical RPM, an adjacent competitor for the same healthcare and senior-living decision-makers.
  • Xandar Kardian: Radar-based vital sign and occupancy monitoring for healthcare and smart-building applications, an adjacent contactless monitoring peer competing for similar remote patient and facility monitoring budgets.
  • Biovitals: Contactless physiological monitoring using video analysis for clinical and remote patient use cases, a closer emerging competitor in the same contactless vitals category.
  • Aerial: Computer vision platform for contact-free health monitoring in senior living and home care, addressing the same elderly/frail and assisted-living customer segment as Signum.

Direct peers

  • Binah.ai: Provides contactless vital signs monitoring (heart rate, SpO2, blood pressure, stress) via video from smartphones or cameras, directly overlapping ROSIE's core passive optical physiology capability across both healthcare and workforce screening.
  • NuraLogix: Developer of TransDERMAL and Anura platforms that extract vital signs and health risk indicators from video, a direct technological analogue to ROSIE's AI/computer-vision vital sign approach.
  • Oxehealth: Uses cameras and computer vision for contactless vital sign and activity monitoring in clinical and senior care settings, closely mirroring Signum's healthcare and senior living use cases.

Broad incumbents

  • Anduril Industries: Large defense-tech incumbent building AI sensing and surveillance for DHS/CBP and other federal agencies; a strategic reference point for AI-driven critical-infrastructure security customers that Signum is also targeting.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights5 records

Customer concentration

Signum Technologies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Signum Technologies leadership team

Management profile

Number of profiles

Profiles3 records

Signum Technologies funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Signum Technologies M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Signum Technologies

What does Signum Technologies do?

Signum Technologies develops and sells ROSIE, a patented passive optical physiology monitoring software that uses computer vision and artificial intelligence to perform contactless vital sign monitoring. The product scans individuals in bulk to identify those whose vital signs fall outside normal parameters without any physical contact, enabling deployment in healthcare (senior living, NICUs, burn centers, telehealth) and government health security (airports, ports, border crossings) settings.

Is Signum Technologies a public or private company?

Signum Technologies is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Signum Technologies founded?

Signum Technologies was founded in 2022. It employs 1 to 10 people.

Where is Signum Technologies based?

Signum Technologies is headquartered in Radnor, United States, in the North America region.

How does Signum Technologies make money?

One revenue line is on record: SEC Exempt Securities Offering.

Who are Signum Technologies's main competitors?

Emerging players on record are EarlySense, Care.ai, BioIntellisense, Xandar Kardian, Biovitals and Aerial. Direct peers are Binah.ai, NuraLogix and Oxehealth. Anduril Industries is listed as a broad incumbent.

Does Signum Technologies have an API?

No public API is recorded for Signum Technologies.

What industry is Signum Technologies in?

Signum Technologies's product category is Computer Vision Healthcare Monitoring Software. Its primary akta.pro industry code is HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration), with a secondary code of HLACAFAE, Elderly/Frail & Assisted Living Connected Care (PERS/Fall Detection). Its NAICS code is 334510 and its SIC code is 3823.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales